Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Risk Factors for Community- and Workplace Transmission of COVID-19

  • Read more about Risk Factors for Community- and Workplace Transmission of COVID-19

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

  • Read more about Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19)

  • Read more about Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19)

TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

  • Read more about TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

Fenofibrate for Patients With COVID-19 Requiring Hospitalization

  • Read more about Fenofibrate for Patients With COVID-19 Requiring Hospitalization

A Cross-sectional, Observational Study to Characterise Long COVID-19 in an Urban Sample of South African Adults

  • Read more about A Cross-sectional, Observational Study to Characterise Long COVID-19 in an Urban Sample of South African Adults

Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients

  • Read more about Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients

Post COVID-19 Biorepository

  • Read more about Post COVID-19 Biorepository

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

  • Read more about International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic

  • Read more about COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 183
  • Page 184
  • Page 185
  • Page 186
  • Current page 187
  • Page 188
  • Page 189
  • Page 190
  • Page 191
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA